Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Professional ethics. Deontology --- Science --- Social sciences --- Research --- Moral and ethical aspects --- Social scientists --- Samhällsvetenskaplig forskning --- Moral and ethical aspects. --- Professional ethics. --- etik och moral --- etik och moral. --- Etik och moral.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Social sciences --- Social scientists

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Victims of crimes --- -Crime victims --- Victimology --- Victims --- Congresses --- Criminologie --- Enquetes de victimisation --- Reparation --- Victimologie --- Violence contre les femmes

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Successfully fighting cancer starts with understanding how it begins. This thoroughly revised 3rd Edition explores the scientific basis for our current understanding of malignant transformation and the pathogenesis and treatment of cancer. A team of leading experts thoroughly explain the molecular biologic principles that underlie the diagnostic tests and therapeutic interventions now being used in clinical trials and practice. Incorporating cutting-edge advances and the newest research, the book provides thorough descriptions of everything from molecular abnormalities in common cancers to new approaches for cancer therapy. A new full-color format expedites reference, and a new bonus Expert Consult Edition website enables you to search the full text, download all of the book’s images for your personal use, and review periodic updates. New to this edition Features numerous descriptions of the latest clinical strategies—helping you to understand and take advantage of today’s state-of-the-art biotechnology advances. By John Mendelsohn, MD, Professor, Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas ; Peter M. Howley, MD, Shattuck Professor of Pathological Anatomy, Department of Microbiology and Immunobiology, Division of Immunology, Harvard Medical School, Boston, Massachusetts ; Mark A. Israel, MD, Director, Norris Cotton Cancer Center, Professor of Pediatrics and Genetics, Dartmouth Medical School, Hanover, New Hampshire; Joe W. Gray, PhD, Gordon Moore Professor and Chair, Biomedical Engineering, Oregon Health and Science University (OHSU) Director, OHSU Center for Spatial Systems Biomedicine, Portland, Oregon; Emeritus Professor, UCSF, and Visiting Faculty, Lawrence Berkeley National Laboratory, Berkeley, California and Craig B. Thompson, MD, President and CEO, Memorial Sloan-Kettering Cancer Center, New York, New York Table of Contents: Part I: Carcinogenesis and Cancer Genetics 1. Cancer, A Genetic Disorder 2. Oncogenes and Signal Transduction 3. Tumor Suppressor Genes 4. Genomic Instability and DNA Repair 5. Epigenetics and Cancer 6. Infectious Agents and Cancer 7. Environmental Carcinogenesis 8. Animal Models: Flies, Fish and Yeast 9. Genetic Mouse Models of Cancer Part II: Cancer Biology 10. Cancer Stem Cells 11. Regulation of the Cell Cycle 12. Cell Growth 13. Cancer Cell Metabolism 14. Apoptosis, Autophagy and Necrosis 15. Cell Growth Arrest and Senescence 16. Stromal-Cancer Interactions in the Microenvironment 17. Hypoxia and Angiogenesis 18. Invasion and Metastasis 19. Inflammation and Cancer 20. Molecular Pathways and Systems Biology Part III: Molecular Pathology and Diagnostics 21. Biomarkers Assessing Risk of Cancer 22. Biomarkers for Detecting Cancer: Molecular Screening 23. Biomarkers for Predicting Response to Specific Therapy 24. The Technology of Analyzing Nucleic Acids 25. Imaging Cancer

Neoplasms --- Molecular Targeted Therapy. --- Molecular Biology --- Molecular biology -- Methods. --- Molecular targeted therapy. --- Neoplasms -- Genetics. --- Neoplasms -- Pathology. --- Medicine --- Health & Biological Sciences --- Oncology --- genetics. --- pathology. --- methods. --- Targeted Molecular Therapy --- Molecular Targeted Therapies --- Molecular Therapy, Targeted --- Targeted Molecular Therapies --- Targeted Therapy, Molecular --- Therapy, Molecular Targeted --- Therapy, Targeted Molecular --- Molecular Targeted Therapy

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The distinction between complements, substitutes, and independent goods is important in many contexts. It is well known that when consumers' conditional indirect utilities for two goods are superadditive, the goods are gross complements. Generalizing insights in Gans and King (2006) and Gentzkow (2007), we show that superadditivity between one pair of goods can also introduce complementarity between competing pairs of goods. One implication is that lower prices can result from a merger between producers of goods that themselves offer no superadditivity.